CIK 0001946573 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Nakamoto Inc.
Sign in to watch- Tickers
- NAKA NAKAW
- Exchange
- Nasdaq, OTC
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843829824
- Phone
- (385) 388-8220
- Business address
- 300 10TH AVE SOUTH, NASHVILLE, TN, 37203
- Former names
- Kindly MD, Inc.
Securities
- NAKA Common Stock Nasdaq
- NAKAW Common stock OTC
- Open-market buys, last 90 days
- $235,151
- in 2 filings
- Open-market sales, last 90 days
- $7,493
- in 1 filing
Net +$227,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award · Stock Option | +2,470,803 | 25,421,822 | ||
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award · Stock Option | +3,596,392 | 25,421,822 | ||
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award · Stock Option | +2,745,337 | 25,421,822 | ||
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award · Stock Option | +12,491,284 | 25,421,822 | ||
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award | +17,841,993 | 20,252,858 | ||
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award · Stock Option | +4,118,006 | 25,421,822 | ||
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award · Stock Option | +2,470,803 | 25,421,822 | ||
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award · Stock Option | +3,596,392 | 25,421,822 | ||
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award · Stock Option | +2,745,337 | 25,421,822 | ||
| 2026-02-20 | Evans Tyler Matthew Chief Investment Officer | Grant or award · Stock Option | +12,491,284 | 25,421,822 | ||
| 2026-02-20 | Bailey David F Chief Executive Officer | Grant or award | +108,200,628 | 119,361,200 | ||
| 2026-02-20 | Creighton Andrew John Chief Commercial Officer | Grant or award · Stock Option | +1,685,500 | 1,685,500 | ||
| 2025-12-16 | Dalton John Merritt Chief Accounting Officer | Grant or award | +1,574,803 | 1,574,803 | ||
| 2025-12-16 | Gendron Teresa S Chief Financial Officer | Grant or award | +2,624,671 | 2,624,671 | ||
| 2025-09-22 | Barrera Jared Chief Financial Officer | Grant or award | +6,400 | 22,242 | ||
| 2025-09-22 | Pickett Timothy Chief Medical Officer | Grant or award | +37,593 | 136,618 | ||
| 2025-09-22 | Pickett Timothy Chief Medical Officer | Grant or award | +26,129 | 162,747 | ||
| 2025-09-22 | Pickett Timothy Chief Medical Officer | Grant or award | +10,146 | 172,893 | ||
| 2025-09-22 | Pickett Timothy Chief Medical Officer | Grant or award | +18,378 | 191,271 | ||
| 2025-09-22 | Weiss Eric Stanton Director | Grant or award | +112,781 | 112,781 |
Page 3 of 5 · 89 trades